Skip to main content
Michael Soike, MD, Radiation Oncology, Birmingham, AL

MichaelSoikeMD(He/Him)

Radiation Oncology Birmingham, AL

Breast Cancer, Pediatric Radiation Oncology, Thoracic Cancer

Assistant Professor

Dr. Soike is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Soike's full profile

Already have an account?

  • Office

    619 19th St S
    Birmingham, AL 35249
    Phone+1 336-716-2011
    Fax+1 209-975-0784

Summary

  • Dr. Michael Soike is a radiation oncologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including Russell Medical and University of Alabama Hospital. He received his medical degree from Wake Forest School of Medicine of Wake Forest Baptist Medical Center and has been in practice 3 years. He specializes in breast cancer, pediatric radiation oncology, and thoracic cancer.

Education & Training

  • Wake Forest University Baptist Medical Center
    Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2019
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2014

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2019 - 2024
  • NC State Medical License
    NC State Medical License 2014 - 2019
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Journal Articles

  • Oxford University Press Has Registered This DOI Pre-Publication  
    Michael H Soike, Michael D Chan, Christina K Cramer, Ryan T Hughes, Michael Farris, Emory R McTyre, Oxford University Press

Press Mentions

  • CD138 Plasma Cells May Predict Brain Metastasis Recurrence Following Resection and Stereotactic Radiosurgery
    CD138 Plasma Cells May Predict Brain Metastasis Recurrence Following Resection and Stereotactic RadiosurgeryOctober 7th, 2019